ADIM
OMCL icon

Alpha DNA Investment Management’s Omnicell OMCL Stock Holding History

Alpha DNA Investment Management’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,626
Closed -$429K – 121
2024
Q4 		$429K Buy
+9,626
New +$432K 0.16% 151

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's OMCL Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Omnicell (OMCL) in Q1 2025, closing a stake of 9,626 shares — an estimated $429K sold.

Alpha DNA Investment Management first reported a position in OMCL in Q4 2024 and held it in 1 quarter. The position peaked at $429K in Q4 2024. 274 funds tracked by Wall St. Rank hold OMCL as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Omnicell position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,626 Omnicell shares in Q1 2025, an estimated $429K.
  • Alpha DNA Investment Management first reported a position in Omnicell in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Omnicell position peaked at $429K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Omnicell as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.